Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Bayesian two-stage designs for phase II clinical trials.

Say-Beng Tan1, David Machin

  • 1Division of Clinical Trials & Epidemiological Sciences, National Cancer Centre, Singapore. ctetsb@nccs.com.sg

Statistics in Medicine
|July 12, 2002
PubMed
Summary

This study introduces two new user-friendly Bayesian designs for phase II clinical trials. These methods offer an intuitive alternative to frequentist approaches, incorporating prior information for more accessible trial results.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cuboid dislocations: Short and long term results and a review of the literature.

Foot (Edinburgh, Scotland)·2026
Same author

A novel strategy for conversion from pediatric V-A ECMO to CPB circuit.

The journal of extra-corporeal technology·2025
Same author

International neuroblastoma risk group consortium: a model of networking for rare cancers.

Journal of the National Cancer Institute·2025
Same author

Hypobaric type oxygenators - physics and physiology.

Perfusion·2024
Same author

Caffeine ingestion stimulates plasma carnitine clearance in humans.

Physiological reports·2023
Same author

The prognostic strength of serum LDH and serum ferritin in children with neuroblastoma: A report from the International Neuroblastoma Risk Group (INRG) project.

Pediatric blood & cancer·2020

Area of Science:

  • Biostatistics
  • Clinical Trial Design
  • Bayesian Methodology

Background:

  • Frequentist statistical approaches dominate phase II clinical trial designs.
  • Bayesian methods offer advantages by incorporating prior information and providing intuitive results.

Purpose of the Study:

  • To propose two novel Bayesian designs for phase II clinical trials.
  • To enhance user-friendliness and familiarity for those experienced with frequentist designs.
  • To avoid complex requirements like prior response rate distributions or utility functions.

Main Methods:

  • Development of two new Bayesian phase II clinical trial designs.
  • Comparison of proposed designs with established frequentist methods (Simon's two-stage optimal and minimax).
  • Application of designs to real-world phase II clinical trial data.

Related Experiment Videos

Main Results:

  • The proposed Bayesian designs are user-friendly and comparable to frequentist designs.
  • Demonstrated applicability to actual clinical trial scenarios.
  • Provided sample size tables for practical implementation.

Conclusions:

  • The new Bayesian designs offer a practical and intuitive alternative for phase II clinical trials.
  • These methods simplify Bayesian adoption by reducing reliance on complex statistical specifications.
  • The designs are suitable for researchers familiar with traditional frequentist approaches.